Allergan Inc. v Sandoz Canada Inc. et al.

Call to arrange a consultation

2018

T-2023-18

Resolved

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)

Counsel to:

Sandoz Canada Inc.

The decision is reported

Counsel

Associate